Literature DB >> 19143007

Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.

Kaarthik John1, Narasimhan Ragavan, M Margaret Pratt, Paras B Singh, Salah Al-Buheissi, Shyam S Matanhelia, David H Phillips, Miriam C Poirier, Francis L Martin.   

Abstract

BACKGROUND: Studies of migrant populations suggest that dietary and/or environmental factors play a crucial role in the etiology of prostatic adenocarcinoma (CaP). The human prostate consists of the peripheral zone (PZ), transition zone (TZ), and central zone (CZ); CaP occurs most often in the PZ.
METHODS: To investigate the notion that an underlying differential expression of phase I/II genes, and/or the presence of polycyclic aromatic hydrocarbon (PAH)-DNA adducts might explain the elevated PZ susceptibility, we examined prostate tissues (matched tissue sets consisting of PZ and TZ) from men undergoing radical retropubic prostatectomy for CaP (n = 26) or cystoprostatectomy (n = 1). Quantitative gene expression analysis was employed for cytochrome P450 (CYP) isoforms CYP1A1, CYP1B1, and CYP1A2, as well as N-acetyltransferase 1 and 2 (NAT1 and NAT2) and catechol-O-methyl transferase (COMT).
RESULTS: CYP1B1, NAT1, and COMT were expressed in all tissue sets; levels of CYP1B1 and NAT1 were consistently higher in the PZ compared to TZ. Immunohistochemistry confirmed the presence of CYP1B1 (nuclear-associated and primarily in basal epithelial cells) and NAT1. Normal tissue from 23 of these aforementioned 27 matched tissue sets was analyzed for PAH-DNA adduct levels using antiserum elicited against DNA modified with r7,t8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydro-benzo[a]pyrene (BPDE). PAH-DNA adduct levels were highest in glandular epithelial cells, but a comparison of PZ and TZ showed no significant differences.
CONCLUSION: Although expression of activating and/or detoxifying enzymes may be higher in the PZ, PAH-DNA adduct levels appear to be similar in both zones. Therefore, factors other than PAH-DNA adducts may be responsible for promotion of tumor formation in the human prostate. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143007      PMCID: PMC2647988          DOI: 10.1002/pros.20898

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  59 in total

1.  Heterocyclic aromatic amines induce DNA strand breaks and cell transformation.

Authors:  W Pfau; F L Martin; K J Cole; S Venitt; D H Phillips; P L Grover; H Marquardt
Journal:  Carcinogenesis       Date:  1999-04       Impact factor: 4.944

Review 2.  Changing demography of prostate cancer in Asia.

Authors:  Hong Gee Sim; Christopher W S Cheng
Journal:  Eur J Cancer       Date:  2005-04       Impact factor: 9.162

Review 3.  Drug-metabolizing enzymes: mechanisms and functions.

Authors:  S A Sheweita
Journal:  Curr Drug Metab       Date:  2000-09       Impact factor: 3.731

Review 4.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

5.  Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens.

Authors:  Terence Lawson; Carol Kolar
Journal:  Cancer Lett       Date:  2002-01-25       Impact factor: 8.679

Review 6.  A unified mechanism in the initiation of cancer.

Authors:  Ercole L Cavalieri; Eeanor G Rogan
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

7.  Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue.

Authors:  Dawn M Carnell; Rowena E Smith; Frances M Daley; Paul R Barber; Peter J Hoskin; George D Wilson; Graeme I Murray; Steven A Everett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

8.  Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.

Authors:  M Margaret Pratt; Paul Sirajuddin; Miriam C Poirier; Mark Schiffman; Andrew G Glass; David R Scott; Brenda B Rush; Ofelia A Olivero; Philip E Castle
Journal:  Mutat Res       Date:  2007-05-05       Impact factor: 2.433

9.  Cancer patterns of four ethnic groups in Hawaii.

Authors:  L N Kolonel
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

10.  Polycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomy.

Authors:  Benjamin A Rybicki; Christine Neslund-Dudas; Cathryn H Bock; Andrew Rundle; Adnan T Savera; James J Yang; Nora L Nock; Deliang Tang
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

View more
  22 in total

1.  Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran.

Authors:  Behnoush Abedi-Ardekani; Farin Kamangar; Stephen M Hewitt; Pierre Hainaut; Masoud Sotoudeh; Christian C Abnet; Philip R Taylor; Paolo Boffetta; Reza Malekzadeh; Sanford M Dawsey
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

2.  Metabolic Activation of the Cooked Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine in Human Prostate.

Authors:  Medjda Bellamri; Shun Xiao; Paari Murugan; Christopher J Weight; Robert J Turesky
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

3.  Estrogen action and prostate cancer.

Authors:  Jason L Nelles; Wen-Yang Hu; Gail S Prins
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

4.  The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones.

Authors:  Qi Jiang; Bang-Min Han; Fu-Jun Zhao; Yan Hong; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

5.  Assessment of multiple types of DNA damage in human placentas from smoking and nonsmoking women in the Czech Republic.

Authors:  M Margaret Pratt; Leon C King; Linda D Adams; Kaarthik John; Paul Sirajuddin; Ofelia A Olivero; David K Manchester; Radim J Sram; David M DeMarini; Miriam C Poirier
Journal:  Environ Mol Mutagen       Date:  2011-01       Impact factor: 3.216

6.  Neighborhood socioeconomic status modifies the association between individual smoking status and PAH-DNA adduct levels in prostate tissue.

Authors:  Andrew Rundle; Catherine Richards; Christine Neslund-Dudas; Deliang Tang; Benjamin A Rybicki
Journal:  Environ Mol Mutagen       Date:  2012-03-29       Impact factor: 3.216

7.  Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland.

Authors:  LaCreis R Kidd; David W Hein; Karen Woodson; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Joseph A Tangrea
Journal:  Biochem Genet       Date:  2010-10-08       Impact factor: 1.890

Review 8.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

9.  Association of CYP1B1 Polymorphisms with Breast Cancer: A Case-Control Study in the Han Population in Ningxia Hui Autonomous Region, P. R. China.

Authors:  Haiyan Jiao; Chunlian Liu; Weidong Guo; Liang Peng; Yintao Chen; Francis L Martin
Journal:  Biomark Insights       Date:  2010-02-12

10.  Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.

Authors:  Paras B Singh; Narasimhan Ragavan; Katherine M Ashton; Prabir Basu; Sayeed M Nadeem; Caroline M Nicholson; R K Gopala Krishna; Shyam S Matanhelia; Francis L Martin
Journal:  Asian J Androl       Date:  2009-11-23       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.